Skip to main content

and
  1. Article

    Open Access

    COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group

    To investigate the frequency, profile, and severity of COVID-19 breakthrough infections (BI) in patients with type I diabetes mellitus (T1DM) compared to healthy controls (HC) after vaccination. The second COV...

    Suhrud Panchawagh, Naveen Ravichandran, Bhupen Barman in Rheumatology International (2024)

  2. No Access

    Article

    Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort

    Data on short-term safety of COVID-19 vaccination in patients with systemic sclerosis (SSc) were explored previously in the first COVID-19 vaccination in autoimmune diseases (COVAD) survey conducted in 2021. H...

    Suhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana in Rheumatology International (2023)